2.00
+0.015(+0.76%)
Currency In USD
| Previous Close | 1.99 |
| Open | 1.94 |
| Day High | 2.05 |
| Day Low | 1.9 |
| 52-Week High | 3.04 |
| 52-Week Low | 1.21 |
| Volume | 4.66M |
| Average Volume | 1.76M |
| Market Cap | 744.52M |
| PE | -2.9 |
| EPS | -0.69 |
| Moving Average 50 Days | 1.87 |
| Moving Average 200 Days | 2.14 |
| Change | 0.02 |
If you invested $1000 in Standard BioTools Inc. (LAB) 10 years ago, it would be worth $60.62 as of December 22, 2024 at a share price of $2. Whereas If you bought $1000 worth of Standard BioTools Inc. (LAB) shares 5 years ago, it would be worth $588.24 as of December 22, 2024 at a share price of $2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 19, 2024 1:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced its President and Chief Executive Officer, Michael Egholm, PhD, will present at the upcoming 43rd Annual J.P. Morgan Healthcare Conf
Standard BioTools Appoints Alex Kim as Chief Financial Officer
GlobeNewswire Inc.
Nov 07, 2024 1:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced the appointment of Alex Kim as Chief Financial Officer, effective November 11, 2024. Kim, a c
Standard BioTools to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Oct 31, 2024 12:01 PM GMT
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that its management team will participate in the following investor conferences in the month of November: UBS Global Healthcare Conf